Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...

Pharmaceutical heavyweights Merck & Co. Inc. (NYSE: MRK) and Eli Lilly and Company (NYSE: LLY) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...

Eli Lilly and Company’s LLY stock has declined 15.7% in the past year. The first-quarter earnings miss, guidance cut and some ...

Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) are both among the largest biopharmaceutical businesses in the world, but their growth prospects aren't exactly the same. Nonetheless, the pair handily ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

2. Merck Is More Profitable . Eli Lilly’s operating margin of 24.5% over the last twelve-month period is slightly lower than 33.0% for Merck. This compares with 21.8% and 18.7% figures seen in ...

Merck’s stock has declined by close to 10% since early February after the WHO declared the coronavirus a global health emergency, while Eli Lilly stock has fared much better and gained 15%. The ...

Eli Lilly's stock has performed well over the past year, gaining 116.84%. So far in 2024, the stock has returned 29.45% to investors.

Eli Lilly and Merck & Co. are partnering with Purdue University to launch the Young Institute Pharmaceutical Manufacturing Consortium aimed at pioneering new advances in how medicines are produced.

Pharmaceutical heavyweights Merck & Co. Inc. (NYSE: MRK) and Eli Lilly and Company (NYSE: LLY) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...

Lilly will continue to tussle with generic competition for Cialis in 2019. ... Although I'd rather be holding Eli Lilly shares purchased a year ago, Merck looks like the better stock to buy right now.